The partners will use 4D Path's imaging-based Q-Plasia OncoReader in a Phase II trial testing doublet and triplet regimens comprising Trodelvy, Padcev, and Keytruda.
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.
Doctors began testing PSA levels in the 1980s to monitor diagnosed cancers. By the early 1990s, researchers promoted it for ...
En cas d'insuffisance mitrale, l'échographie est l'examen clef pour évaluer la sévérité de la régurgitation et orienter la stratégie thérapeutique. Illustration avec ce cas clinique commenté par la Dr ...
Grand Pharmaceutical Group Limited a annoncé que la demande d'autorisation de mise sur le marché pour le TLX591-CDx , ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback